ArticleBioMed research international2016

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Shinji Ohtake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.